<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02198001</url>
  </required_header>
  <id_info>
    <org_study_id>B403201318408</org_study_id>
    <nct_id>NCT02198001</nct_id>
  </id_info>
  <brief_title>Prospective Randomized Study: Assessment of PRF Efficacy in Prevention of Jaw Osteonecrosis After Tooth Extraction</brief_title>
  <acronym>PRF</acronym>
  <official_title>Prospective Randomized Clinical Study: Role of Platelet Rich Fibrin (PRF) in the Tooth Extraction Site in the Prevention of Jaw Osteonecrosis on Patients Under Bisphosphonates Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective study will include patients taking or having taken bisphosphonates and
      needing dental extractions.

      The aim of this study is to validate the contribution of PRF (Platelet Rich Fibrin) in tooth
      extraction sites.

      In the test group (PRF) and in the control group (no PRF), we use the same atraumatic
      extraction protocol associated with the same antibiotic procedure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Dental extractions are the main cause of jaw osteonecrosis in patients taking oral or iv
      bisphosphonates.

      This prospective randomized study will include a cohort of 100 patients treated with
      bisphosphonates (for benign or malignant conditions) and requiring dental extractions
      (non-retainable teeth for infectious, traumatic or parodontal reasons). 50 patients will
      benefit of PRF placement in the tooth extraction site (group 1) while 50 patients do not
      (group 2).

      The rest of the procedure will be the same in the 2 arms. In the literature, studies suggest
      a benefit from a long term antibiotherapy before and after tooth extraction. Extraction
      procedure should be the least traumatic as possible.

      The main objective of our study is to assess, after tooth extraction, the contribution of PRF
      in the prevention of jaw osteonecrosis induced by bisphosphonates.

      A follow-up period of one year after extraction is indicated.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">January 2017</completion_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of jaw osteonecrosis after tooth extraction</measure>
    <time_frame>1year</time_frame>
    <description>7 symptoms &gt; 6 weeks for the diagnosis of osteonecrosis:
bone exposure
bone spicule
mucosal inflammation
pain
paresthésias
suppuration
jaw fracture
number of jaw osteonecrosis after tooth extraction in the oral bisphosphonates group in comparison with the IV bisphosphonates group</description>
  </primary_outcome>
  <other_outcome>
    <measure>Contribution of comorbidities factors in the appearance of osteonecrosis</measure>
    <time_frame>1 year</time_frame>
    <description>comorbidities:
diabetes,
immunosuppression (corticoids, chemotherapy, immunosuppressive treatment)
tobacco</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of days in tooth-extraction healing in the two groups</measure>
    <time_frame>2 months</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Bisphosphonate-Associated Osteonecrosis of the Jaw</condition>
  <arm_group>
    <arm_group_label>tooth extraction and insertion of PRF</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Experimental: Atraumatic tooth extraction with antibiotics( amoxicillin clavulanate combination) .Insertion of PRF membrane in tooth-extraction site.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No PRF</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Atraumatic extraction with antibiotic without PRF insertion</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tooth extraction with antibiotics (amoxicillin- clavulanate, clindamycine)</intervention_name>
    <description>BPs per os&lt; 3ans: amoxicillin- clavulanate J-1 à J+10
BPs IV ou per os&gt; 3ans ou per os + comordibities (diabetes, immunosuppression, tobacco):
amoxicillin- clavulanate J-3 à J+10
In case of allergy:
BPs per os: clindamycine J-1 à J+10
BPs IV ou per os&gt; 3ans ou per os + comordibities (diabetes, immunosuppression, tobacco):
clindamycine J-3 à J+10</description>
    <arm_group_label>tooth extraction and insertion of PRF</arm_group_label>
    <arm_group_label>No PRF</arm_group_label>
    <other_name>antibiotherapy before and after extraction</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>atraumatic extraction</intervention_name>
    <description>Atraumatic tooth extraction, alveolar bone reduction, hermetic mucosal closure</description>
    <arm_group_label>tooth extraction and insertion of PRF</arm_group_label>
    <arm_group_label>No PRF</arm_group_label>
    <other_name>- atraumatic tooth extraction</other_name>
    <other_name>- hermetic mucosal closure</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients taking bisphosphonates whatever the indication, the type, the administration
             and the duration of treatment (we include patients taking or having taken
             bisphosphonates, even several years ago)

          -  And who need tooth extraction (not recoverable in conservative dentistry and
             symptomatic tooth: dental and periodontal infections, symptomatic traumatic tooth
             fracture).

        Exclusion Criteria:

          -  pregnant women

          -  younger than 50 years old

          -  jaw's radiotherapy

          -  history of jaw osteonecrosis

          -  jaw metastasis from an other cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hervé P Reychler, MD, DMD</last_name>
    <role>Study Chair</role>
    <affiliation>Cliniques universitaires Saint-Luc</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dorothée L Deneubourg, MD, DDS</last_name>
    <phone>003227645702</phone>
    <phone_ext>003227645774</phone_ext>
    <email>dorothee.deneubourg@uclouvain.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michèle Magremanne, MD, DDS</last_name>
    <phone>003227645711</phone>
    <email>michele.magremanne@uclouvain.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cliniques Universitaires Saint Luc</name>
      <address>
        <city>Bruxelles</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michele Magremanne, MD, DDS</last_name>
      <phone>003227645711</phone>
      <email>michele.magremanne@uclouvain.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitaliser Ambroise Paré</name>
      <address>
        <city>Mons</city>
        <zip>7000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Vervaet, MD DDS</last_name>
      <phone>003265414190</phone>
      <email>catherine.vervaet@hap.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique et maternité Sainte Elisabeth</name>
      <address>
        <city>Namur</city>
        <zip>5000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrice Lejuste, MD, DDS</last_name>
      <phone>003281720631</phone>
      <email>patrice.lejuste@cmsenamur.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 15, 2014</study_first_submitted>
  <study_first_submitted_qc>July 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 23, 2014</study_first_posted>
  <last_update_submitted>July 22, 2014</last_update_submitted>
  <last_update_submitted_qc>July 22, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 23, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Platelets</keyword>
  <keyword>fibrin</keyword>
  <keyword>growth factors</keyword>
  <keyword>bisphosphonates</keyword>
  <keyword>tooth extraction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteonecrosis</mesh_term>
    <mesh_term>Bisphosphonate-Associated Osteonecrosis of the Jaw</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Amoxicillin</mesh_term>
    <mesh_term>Clavulanic Acid</mesh_term>
    <mesh_term>Clavulanic Acids</mesh_term>
    <mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
    <mesh_term>Clindamycin</mesh_term>
    <mesh_term>Clindamycin palmitate</mesh_term>
    <mesh_term>Clindamycin phosphate</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
    <mesh_term>Diphosphonates</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

